Solutions
Innovation determines the future. QT BIO focuses on the research and development and application of isothermal nucleic acid amplification technology and has RAA technology patent authorization. Committed to creating a precise, efficient, fast, and portable nucleic acid detection platform.
People's Daily: RAA nucleic acid testing technology is expected to solve the problem of missed and misdiagnosis of imported schistosomiasis
Release Time:
2023-03-15
On June 22, news that the Jiangsu Institute of Parasitic Disease Prevention and Control had used its independently developed RAA nucleic acid detection technology to diagnose a case of imported schistosomiasis for the first time brought schistosomiasis, once a dreaded disease, back into the public eye. "Due to the lack of relevant diagnostic standards and technologies, the misdiagnosis and missed diagnosis rates of imported schistosomiasis are relatively high. The successful application of this new RAA nucleic acid detection technology for the diagnosis of imported schistosomiasis for the first time is of great significance to rapidly improving the diagnostic level of imported schistosomiasis in China." Yang Kun, deputy director of the Jiangsu Institute of Parasitic Disease Prevention and Control and head of the China-aided Zanzibar schistosomiasis prevention and control project, said in an interview with a reporter from People's Daily Health Client.
Next Page:
QT Biotech Co., Ltd.
Tel: +86-510-85385531
Mobile: +86-18921157475
Email: qt@qt-bio.com
Website: www.qt-bio.com
Address: No. 97, Xingye Building B, Linghu Avenue, Xiwu District, Wuxi City
Racing against time, guarding life safety
WeChat Account
Official Public Account